Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications-Reference-Cited by-同舟云学术

Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications

Published:2020-09-12 Issue:12 Volume:4 Page:1731-1743
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol. Commun.

Author:

Ishay Yuval¹,Kessler Asa¹,Schwarts Asaf¹,Ilan Yaron¹

Affiliation:

1. Department of Medicine Hebrew University‐Hadassah Medical Center Jerusalem Israel

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1600

Reference128 articles.

1. How to reduce the likelihood of coronavirus‐19 (CoV‐19 or SARS‐CoV‐2) infection and lung inflammation mediated by IL‐1;Conti P;J Biol Regul Homeost Agents,2020

2. SARS-CoV-2: a storm is raging

3. Immune responses and pathogenesis ofSARS‐CoV‐2 during an outbreak in Iran: Comparison withSARSandMERS

4. Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future

5. Coronavirus membrane fusion mechanism offers a potential target for antiviral development

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensitivities of a Rapid Test Versus an ELISA Kit for Detecting Anti-SARS-CoV-2 IgM/IgG in Sera from an Egyptian Cohort;Current Microbiology;2023-11-30

2. Clinical importance of zinc as monotherapy in modulating RT-PCR cycle threshold values and antibody levels in cases of COVID 19 patients;PAK J PHARM SCI;2023

3. Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases;Journal of Personalized Medicine;2022-08-10

4. Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants;Microbiology Spectrum;2021-12-22

5. Augmented antiviral T cell immunity by oral administration of IMM‐124E in preclinical models and a phase I/ IIa clinical trial: A method for the prevention and treatment of COVID ‐19;Drug Development Research;2021-10